million

Eightco Holdings Inc. Closes $270 Million Private Placement as First Worldcoin (WLD) Treasury Strategy

Dan Ives, renowned technology and AI expert and Wall Street analyst, to serve as Chairman of the Board In an…

7 months ago

Three global institutions win million dollar prize for the 2025 Antnio Champalimaud Vision Award

Valued at €1 million, it is the world's largest award in the field of vision, recognising work that combines scientific excellence,…

7 months ago

Replit Closes $250 Million in Funding to Build on Customer Momentum

Prysm, a16z, Amex Ventures, Coatue, YC in Round; Joins Google's AI Futures Fund Announces New Autonomous Agent for Enterprises FOSTER…

7 months ago

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program

The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to start the IND-enabling program for the NN-840 program…

7 months ago

Geotab Surpasses 5 Million Global Connected Vehicle Subscriptions

SINGAPORE, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Geotab Inc. (“Geotab”), today announced it has achieved a new company milestone, surpassing…

7 months ago

Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030

September 08, 2025 17:57 ET  | Source: Harrow, Inc. NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider…

7 months ago

NYSE Content Advisory: Pre-Market Update + Biotech Enveda raises $150 million to reach unicorn status

NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

7 months ago

Enfinity Global Secures 316 Million Financing for 276 MW of Solar Projects in Italy

MILAN, Sept. 4, 2025 /PRNewswire/ -- Enfinity Global Inc., a leading renewable energy company, today announced the successful financial close…

7 months ago

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

September 02, 2025 21:33 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

7 months ago

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML

New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla VenturesCHARM’s AI-designed menin inhibitor…

7 months ago